ProFound AI Risk
General Information
Product name
Company
Subspeciality
Modality
Disease targeted
Main task
Not specified
Technical Specifications
Population
Patient population age
Not specified
Input
Input format
Output
Output format
Integration
Deployment
Trigger for analysis
Processing time
Regulatory Information
Pathway:
MDD
Class:
Class I
Other certifications
Not specified
Market Presence
On market since
AI Platforms
Resellers
Countries present
Paying clinical customers
Research/test users
Pricing Information
Pricing model
Not specified
Based on
Not specified
Evidence & Research
Peer-Reviewed Papers
View
European validation of an image-derived AI-based short-term risk model for individualized breast cancer screening—a nested case-control study
View
A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care
View
Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening
Source: vendor | First published: Dec 19, 2023 | Last updated: Jul 9, 2025